122 related articles for article (PubMed ID: 3265720)
1. Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line.
Helseth E; Dalen A; Unsgaard G; Vik R
J Neurooncol; 1988 Nov; 6(3):277-83. PubMed ID: 3265720
[TBL] [Abstract][Full Text] [Related]
2. The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.
Helseth E; Unsgaard G; Dalen A; Vik R
J Neurooncol; 1988 Nov; 6(3):269-76. PubMed ID: 3265719
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.
Laiho M; Saksela O; Keski-Oja J
Exp Cell Res; 1986 Jun; 164(2):399-407. PubMed ID: 3519251
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the plasminogen activator/plasmin system by epidermal growth factor in cultured human endometrial cells.
Miyauchi A; Momoeda M; Nakabayashi M; Osuga Y; Yano T; Tsutsumi O; Taketani Y
Hum Reprod; 1995 Dec; 10(12):3284-8. PubMed ID: 8822459
[TBL] [Abstract][Full Text] [Related]
6. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
Boyd D
Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
[TBL] [Abstract][Full Text] [Related]
7. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
[TBL] [Abstract][Full Text] [Related]
8. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines.
Helseth E; Dalen A; Unsgaard G; Skandsen T; Grøndahl-Hansen J; Lund LR
APMIS; 1988 Sep; 96(9):845-9. PubMed ID: 3262361
[TBL] [Abstract][Full Text] [Related]
10. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
Cheng SL; Shen V; Peck WA
Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
[TBL] [Abstract][Full Text] [Related]
12. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
Keski-Oja J; Koli K
J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor.
Tranque P; Naftolin F; Robbins R
Endocrinology; 1994 Jun; 134(6):2606-13. PubMed ID: 8194486
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin.
Grant MB; Guay C
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):53-64. PubMed ID: 1702773
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
Koli K; Keski-Oja J
J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
[TBL] [Abstract][Full Text] [Related]
17. Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP).
Schuurmans AL; Bolt J; Mulder E
Mol Cell Endocrinol; 1988 Nov; 60(1):101-4. PubMed ID: 3265111
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
De Petro G; Copeta A; Barlati S
Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
[TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
20. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
